THE REGENERON PRIZE FOR CREATIVE INNOVATION Trademark

Trademark Overview

On Thursday, February 25, 2016, a trademark application was filed for THE REGENERON PRIZE FOR CREATIVE INNOVATION with the United States Patent and Trademark Office. The USPTO has given the THE REGENERON PRIZE FOR CREATIVE INNOVATION trademark a serial number of 86920153. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, April 27, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The THE REGENERON PRIZE FOR CREATIVE INNOVATION trademark is filed in the Education & Entertainment Services category with the following description:

Providing recognition and incentives by the way of awards featuring prizes to demonstrate excellence in the biomedical field
the regeneron prize for creative innovation

General Information

Serial Number86920153
Word MarkTHE REGENERON PRIZE FOR CREATIVE INNOVATION
Filing DateThursday, February 25, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, April 27, 2024
Registration Number5312297
Registration DateTuesday, October 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements

Goods and ServicesProviding recognition and incentives by the way of awards featuring prizes to demonstrate excellence in the biomedical field
NOT AVAILABLE"PRIZE FOR CREATIVE INNOVATION"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, March 1, 2016
Primary Code041
First Use Anywhere DateThursday, June 27, 2013
First Use In Commerce DateThursday, June 27, 2013

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, May 2, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, May 2, 2016EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2016EXAMINER'S AMENDMENT ENTERED
Monday, May 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2016ASSIGNED TO LIE
Friday, May 20, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 22, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, February 22, 2017SOU EXTENSION 1 FILED
Wednesday, February 22, 2017SOU EXTENSION 1 GRANTED
Friday, February 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, August 10, 2017USE AMENDMENT FILED
Monday, August 14, 2017SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2017SOU EXTENSION 2 FILED
Thursday, August 24, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 25, 2017SOU EXTENSION 2 GRANTED
Friday, August 25, 2017STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 10, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 30, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, February 29, 2016NEW APPLICATION ENTERED
Tuesday, March 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 2, 2016ASSIGNED TO EXAMINER
Thursday, April 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 27, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 27, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

innovation creative prize regeneron demonstrate excellence biomedical field prizes featuring recognition incentives awards providing